Uncategorized
AMD patients with low luminance vision garner twice the benefit of Lucentis treatment
MIAMI — Vision in dim light improves twice as much as vision in normal light with Lucentis therapy in patients with age-related macular degeneration, Ronald E. Frenkel, MD, FACS, told colleagues at Angiogenesis, Exudation, and Degeneration 2015.“The gap between normal and dim vision at baseline may predict the patient’s response to treatment,” Frenkel said. “A smaller gap may be a manifestation of more mild retinal disease, and a wider gap portends poor vision gains.”